ALBIREO PHARMA INC (ALBO) Stock Analyst Earnings Estimates
NASDAQ:ALBO - Nasdaq - US01345P1066 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.64M -24.33% | 8.31M -13.80% | 40.579M 388.32% | 35.072M -13.57% | 61.913M 76.53% | 148.29M 139.51% | 247.64M 67.00% | 437.82M 76.80% | 636.96M 45.48% | 747.61M 17.37% | 873.18M 16.80% | 993.53M 13.78% | |
| EBITDA YoY % growth | -60.98M -61.15% | -96.08M -57.56% | -123.211M -28.24% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -61.11M -61.28% | -96.27M -57.54% | -123.485M -28.27% | -154.126M -24.81% | -136.578M 11.39% | -65.993M 51.68% | 5.59M 108.47% | 167.17M 2,890.52% | 327.31M 95.79% | 372.01M 13.66% | 462.1M 24.22% | 547.88M 18.56% | |
| Operating Margin | -633.92% | -1,158.48% | -304.31% | -439.46% | -220.60% | -44.50% | 2.26% | 38.18% | 51.39% | 49.76% | 52.92% | 55.14% | |
| EPS YoY % growth | -5.35 -37.89% | -6.87 -28.41% | -6.78 1.31% | -8.20 -20.91% | -6.71 18.08% | -3.76 43.95% | 0.61 116.08% | 6.45 965.78% | 12.91 100.13% | 11.04 -14.50% | 11.22 1.66% | 10.70 -4.64% |
All data in USD
| Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.01 -252.53% | -1.69 22.68% | -1.75 14.00% | -1.71 11.02% | -1.61 19.71% | -1.13 33.43% | -1.33 24.13% | -1.19 30.15% | -1.06 34.56% | -1.77 -57.47% | -1.83 -37.16% | -1.90 -58.97% |
| Revenue Q2Q % growth | 10.038M -69.13% | 11.82M 73.01% | 13.128M 59.98% | 14.708M 49.59% | 18.509M 84.39% | 18.462M 56.19% | 18.564M 41.41% | 18.768M 27.60% | 19.074M 3.05% | 22.032M 19.34% | 22.134M 19.23% | 22.236M 18.48% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -40.301M -250.63% | -35.685M 9.79% | -34.324M 7.74% | -34.206M 1.30% | -31.172M 22.65% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -1.92 4.95% | -1.08 | -0.84 | -78.30% |
| Q2 2022 Q2Q % growth | -2.04 -7.37% | -1.68 | -0.36 | -21.09% |
| Q1 2022 Q2Q % growth | -2.19 4.37% | -1.89 | -0.30 | -15.85% |
| Q4 2021 Q2Q % growth | -0.57 56.15% | -1.38 | 0.81 | 58.61% |
| Q3 2021 Q2Q % growth | -2.02 -3.06% | -0.39 | -1.63 | -421.16% |
| Q2 2021 Q2Q % growth | -1.90 -37.68% | -2.01 | 0.11 | 5.32% |
| Q1 2021 Q2Q % growth | -2.29 -2.69% | -1.80 | -0.49 | -27.11% |
| Q4 2020 Q2Q % growth | -1.30 -47.73% | -1.98 | 0.68 | 34.35% |
| Q3 2020 Q2Q % growth | -1.96 -13.29% | -1.54 | -0.42 | -27.26% |
| Q2 2020 Q2Q % growth | -1.38 -2.22% | -1.72 | 0.34 | 19.89% |
| Q1 2020 Q2Q % growth | -2.23 -60.43% | -1.39 | -0.84 | -60.17% |
| Q4 2019 Q2Q % growth | -0.88 | -1.62 | 0.74 | 45.61% |
| Q3 2019 Q2Q % growth | -1.73 | -1.59 | -0.14 | -8.98% |
| Q2 2019 Q2Q % growth | -1.35 | -1.46 | 0.11 | 7.45% |
| Q1 2019 Q2Q % growth | -1.39 | -1.34 | -0.05 | -3.43% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | 9.832M 168.34% | 9.736M | 96K | 0.99% |
| Q2 2022 Q2Q % growth | 8.206M 237.97% | 7.604M | 602K | 7.92% |
| Q1 2022 Q2Q % growth | 6.832M 246.80% | 8.122M | -1.29M | -15.88% |
| Q4 2021 Q2Q % growth | 32.521M 1,095.63% | 12.734M | 19.787M | 155.39% |
| Q3 2021 Q2Q % growth | 3.664M 72.02% | 3.555M | 109K | 3.07% |
| Q2 2021 Q2Q % growth | 2.428M 27.12% | 2.018M | 410K | 20.32% |
| Q1 2021 Q2Q % growth | 1.97M 27.10% | 2.177M | -207K | -9.51% |
| Q4 2020 Q2Q % growth | 2.72M -57.70% | 2.392M | 328K | 13.71% |
| Q3 2020 Q2Q % growth | 2.13M 53.24% | 1.658M | 472K | 28.47% |
| Q2 2020 Q2Q % growth | 1.91M 52.80% | 1.306M | 604K | 46.25% |
| Q1 2020 Q2Q % growth | 1.55M 171.93% | 1.054M | 496K | 47.06% |
| Q4 2019 Q2Q % growth | 6.43M | 1.572M | 4.858M | 309.03% |
| Q3 2019 Q2Q % growth | 1.39M | 978.568K | 411.432K | 42.04% |
| Q2 2019 Q2Q % growth | 1.25M | 781.963K | 468.037K | 59.85% |
| Q1 2019 Q2Q % growth | 570K | 993.48K | -423.48K | -42.63% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -7.4% | -7.4% | -1.4% | -17.75% |
| Revenue | -0.45% | -0.4% | -1.08% | -0.96% |